Literature DB >> 15212115

Cortical silent period prolongation in spinocerebellar ataxia type 2 (SCA2).

Domenico A Restivo1, Sara Lanza, Salvatore Giuffrida, Francesco Le Pira, Maria Teresa Drago, Rosario Di Mauro, Agostino Palmeri, Daniela Puzzo, Daniela Puzo, Paolo Di Bella, Edoardo Sessa, Carmela Rifici, Giangaetano D'Aleo, Nunzio Muscarà, Placido Bramanti.   

Abstract

Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disorder mapped on chromosome 12. Different results have been reported in spinocerebellar ataxias following transcranial magnetic stimulation (TMS). TMS-induced cortical silent period (CSP) was prolonged in different cerebellar disorders. Here we evaluate the duration of the TMS-induced CSP following a single magnetic stimulus in a large homogeneous group of SCA2 patients compared with idiopathic cerebellar ataxia (IDCA) patients with similar disease duration and severity, and in 20 healthy controls. The CSP duration in both arm and leg muscles was significantly (p<0.005) longer in patients than in controls. A significant positive correlation between disease duration and CSP prolongation in both SCA2 and IDCA was found. No correlation between age, onset and CSP duration emerged in either group. This study shows a prolongation of the TMS-induced silent period in both SCA2 and IDCA indicating that the cortical inhibitory mechanism is dependent on the disease duration and severity. Thus, the cerebellum seems to exert a pliable physiological influence on the cortico-spinal system through control of inhibitory cortical interneurons.

Entities:  

Mesh:

Year:  2004        PMID: 15212115

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  6 in total

Review 1.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

2.  Different cortical excitability profiles in hereditary brain iron and copper accumulation.

Authors:  Raffaele Dubbioso; Lucia Ruggiero; Marcello Esposito; Paola Tarantino; Marcello De Angelis; Francesco Aruta; Sabina Pappatà; Lorenzo Ugga; Alberto Piperno; Raffaele Iorio; Lucio Santoro; Rosa Iodice; Fiore Manganelli
Journal:  Neurol Sci       Date:  2019-11-26       Impact factor: 3.307

Review 3.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

4.  Clinical and neurophysiological profile of four German families with spinocerebellar ataxia type 14.

Authors:  Christos Ganos; Simone Zittel; Martina Minnerop; Odette Schunke; Christina Heinbokel; Christian Gerloff; Christine Zühlke; Peter Bauer; Thomas Klockgether; Alexander Münchau; Tobias Bäumer
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

Review 5.  Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.

Authors:  Luis C Velázquez-Pérez; Roberto Rodríguez-Labrada; Juan Fernandez-Ruiz
Journal:  Front Neurol       Date:  2017-09-11       Impact factor: 4.003

Review 6.  The Multiple Faces of Spinocerebellar Ataxia type 2.

Authors:  Antonella Antenora; Carlo Rinaldi; Alessandro Roca; Chiara Pane; Maria Lieto; Francesco Saccà; Silvio Peluso; Giuseppe De Michele; Alessandro Filla
Journal:  Ann Clin Transl Neurol       Date:  2017-08-10       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.